Delaware Intellectual Property Cases
Cases 61 - 70 of 1,131
Pfizer Inc. et al v. Aurobindo Pharma Limited
as 1:2023cv01182
Plaintiff:
Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V. and others
Defendant:
Aurobindo Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Hikma Pharmaceuticals USA Inc. v. Cipla USA, Inc. et al
as 1:2023cv01157
Plaintiff:
Hikma Pharmaceuticals USA Inc.
Defendant:
Cipla USA, Inc. and Cipla Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Healthcare LLC et al v. Padagis Israel Pharmaceuticals Ltd., et al
as 1:2023cv01148
Plaintiff:
Bayer Healthcare LLC and Meda Pharmaceuticals Inc.
Defendant:
Padagis Israel Pharmaceuticals Ltd., Padagis US LLC and Padagis LLC
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Fresenius Kabi USA, LLC et al v. Caplin Steriles Ltd. et al
as 1:2023cv01144
Plaintiff:
Fresenius Kabi USA, LLC and Fresenius Kabi Deutschland GmbH
Defendant:
Caplin Steriles Ltd. and Caplin Steriles USA Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Bayer Intellectual Property Gmbh, et al. v. Auson Pharmaceuticals Inc., et al.
as 1:2023cv01103
Counter Defendant:
Bayer Intellectual Property GMBH
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals Inc.
Defendant:
Auson Pharmaceuticals, Inc. and Auson Pharmaceuticals Co., Ltd.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Orphalan SA v. Novitium Pharma LLC
as 1:2023cv01079
Plaintiff:
Orphalan SA
Defendant:
Novitium Pharma LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Azurity Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals, Inc.
as 1:2023cv01080
Plaintiff:
Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC and Takeda Pharmaceutical Company Limited
Defendant:
Teva Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Fresenius Kabi USA, LLC v. Meitheal Pharmaceuticals, Inc.
as 1:2023cv01050
Plaintiff:
Fresenius Kabi USA, LLC
Defendant:
Meitheal Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Celgene Corporation et al v. Natco Pharma Limited
as 1:2023cv01019
Plaintiff:
Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant:
Natco Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Heron Therapeutics, Inc. v. Mylan Pharmaceuticals Inc.
as 1:2023cv01015
Plaintiff:
Heron Therapeutics, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
